Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_assertion type Assertion NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_head.
- NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_assertion description "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_provenance.
- NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_assertion evidence source_evidence_literature NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_provenance.
- NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_assertion SIO_000772 22492511 NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_provenance.
- NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_assertion wasDerivedFrom befree-20140225 NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_provenance.
- NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_assertion wasGeneratedBy ECO_0000203 NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_provenance.